Govt cracks down on erring pharma units

Shimla: Amid the ongoing anti-drug campaign launched on Nov 15, the Himachal Pradesh Police and drug administration on Wednesday conducted an inspection of the pharmaceutical manufacturing units and uncovered irregularities in four facilities.

These facilities had been either closed, suspended or had surrendered their licenses. The officials concerned confirmed that legal action was being initiated against all the violators.

A total of 20 such pharmaceutical units across the state were inspected on Wednesday to curb the illegal production and trafficking of controlled substances.

Joint teams of police officers and drug inspectors carried out systematic checks, verifying licences, scrutinising documents, auditing stock records, and searching warehouses and production areas, said an official spokesperson.

The drive aims to prevent the misuse of inactive units for manufacturing counterfeit or psychotropic drugs. Surprise inspections were conducted across six districts — Una, Bilaspur, Solan, Sirmaur, and Nurpur and Baddi (police districts), said the spokesperson, adding that five more units were still under review.

The state police said it had a ‘zero-tolerance policy’ toward drug-related offences.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’